Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Open accessThe DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Abstract
Hypoxia and free radicals, such as reactive oxygen and nitrogen species, can alter the function and/or activity of the transcription factor hypoxia-inducible factor 1 (HIF1). Interplay between free radicals, hypoxia and HIF1 activity is complex and can influence the earliest stages of tumour development. The hypoxic environment of tumours is heterogeneous, both spatially and temporally, and can change in response to cytotoxic therapy. Free radicals created by hypoxia, hypoxia-reoxygenation cycling and immune cell infiltration after cytotoxic therapy strongly influence HIF1 activity. HIF1 can then promote endothelial and tumour cell survival. As discussed here, a constant theme emerges: inhibition of HIF1 activity will have therapeutic benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many human cancers contain regions of hypoxia because of rapid cell proliferation and the presence of intratumoral blood vessels that are structurally and functionally abnormal, resulting in both spatial and temporal heterogeneity of blood flow (1, 2).”
From Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ROS production later stabilizes the HIF-1α protein and increases expression of HIF-1α and its target genes (Moeller et al., 2004;Dewhirst et al., 2008;Harada et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Dewhirst et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kasuno, K., Takabuchi, S., Fukuda, K., Kizaka-Kondoh, S., Yodoi, J., Adachi, T., Semenza, G. L., & Hirota, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308197200 · Cited by 226
RetractedPlum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,364
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 1×
“The HIF1α subunit is exquisitely regulated by hydroxylation of proline residues in its oxygen-dependent degradation domain (ODD) that target it for recognition by the von Hippel Lindau (VHL) complex and subsequent proteasomal degradation under aerobic condition”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“Origins of hypoxia in solid tumours The presence of hypoxia in tumours is a well-established source of resistance to radiation therapy and chemotherap”
Background
Cited by
Items 601–700 of 999
Molecular and Cellular Response of the Myocardium (H9C2 Cells) Towards Hypoxia and HIF-1α Inhibition
Osuru, H. P., Lavallee, M., & Thiele, R. H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.711421 · Cited by 20
Mittal, S., & Mallia, M. B. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106687 · Cited by 20
Warren, D., & Partridge, M. (2016) · Physics in Medicine and Biology · doi:10.1088/1361-6560/61/24/8596 · Cited by 21
AKT as locus of cancer positive feedback loops and extreme robustness
Radisavljevic, Z. M. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24167 · Cited by 19
“…by increased glycolysis (Warburg effect), cell proliferation, migration, angiogenesis with formation of the cancer vascular shunts, and development of multidrug resistance at the same time (Radisavljevic, 2004a, 2008, 2012; Comerford et al., 2002; Dewhirst et al., 2008; Pries et al., 2010).”
BackgroundImpaired response of mature adipocytes of diabetic mice to hypoxia
Hong, S. J., Jin, D. P., Buck, D. W., Galiano, R. D., & Mustoe, T. A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.07.004 · Cited by 20
Screening of a Novel Peptide Targeting the Proteoglycan-Like Region of Human Carbonic Anhydrase IX
Rana, S., Nissen, F., Lindner, T., Altmann, A., Mier, W., Debus, J., Haberkorn, U., & Askoxylakis, V. (2013) · Molecular Imaging · doi:10.2310/7290.2013.00066 · Cited by 20
T1 based oxygen-enhanced MRI in tumours; a scoping review of current research
McCabe, A., Martin, S. G., Shah, J., Morgan, P. S., & Panek, R. (2023) · British Journal of Radiology · doi:10.1259/bjr.20220624 · Cited by 19
A generic cycling hypoxia-derived prognostic gene signature: application to breast cancer profiling
Boidot, R., Branders, S., Helleputte, T., Rubio, L. I., Dupont, P., & Féron, O. (2014) · Oncotarget · doi:10.18632/oncotarget.2285 · Cited by 21
Szala, S., Mitrus, I., & Sochanik, A. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0873-6 · Cited by 19
High-intensity focused ultrasound plus concomitant radiotherapy: a new weapon in oncology?
Borasi, G., Russo, G. I., Alongi, F., Nahum, A. E., Candiano, G., Stefano, A., Gilardi, M. C., & Messa, C. (2013) · Journal of Therapeutic Ultrasound · doi:10.1186/2050-5736-1-6 · Cited by 18
Arai, M., Kawachi, T., Kotoku, N., Nakata, C., Kamada, H., Tsunoda, S., Tsutsumi, Y. M., Endo, H., Inoue, M., Sato, H., et al. (2015) · ChemBioChem · doi:10.1002/cbic.201500519 · Cited by 19
Goos, J. A. C. M., the DeCoDe PET Group, Coupé, V. M. H., van de Wiel, M. A., Diosdado, B., Diemen, P. M. D., Hiemstra, A. C., de Cuba, E. M. V., Beliën, J. A. M., van Oordt, C. W. M. D. H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6188 · Cited by 18
Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET
Tsujikawa, T., Asahi, S., Oh, M., Sato, Y., Narita, N., Makino, A., Mori, T., Kiyono, Y., Tsuchida, T., Kimura, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155635 · Cited by 17
New Directions in the Study and Treatment of Metastatic Cancer
Yoo, B., Fuchs, B. C., & Medarova, Z. O. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00258 · Cited by 18
Zhu, C., Li, M., Vincent, T., Martin, H. L., Crouch, B. T., Martinez, A. F., Madonna, M. C., Palmer, G. M., Dewhirst, M. W., & Ramanujam, N. (2019) · Journal of Biophotonics · doi:10.1002/jbio.201800372 · Cited by 19
Self-citationHoang, M., & Joseph, J. W. (2020) · Islets · doi:10.1080/19382014.2020.1802183 · Cited by 17
Zheng, N., Zhang, S., Wang, L., Qi, Z., Peng, Q., Jian, L., Bai, Y., Feng, Y. M., Shen, J., Wang, R., et al. (2021) · Nano Research · doi:10.1007/s12274-021-3814-0 · Cited by 17
Sanduleanu, S., Hamming‐Vrieze, O., Wesseling, F. W. R., Even, A. J. G., Hoebers, F. J. P., Hoeben, A., Vogel, W. V., Tesselaar, M. E. T., Parvin, D., Bartelink, H. G. M. M., et al. (2020) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2020.04.004 · Cited by 24
Zhou, D., Visk, D., & Haddad, G. G. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181b27275 · Cited by 19
Measuring tumor cycling hypoxia and angiogenesis using a side‐firing fiber optic probe
Yu, B., Shah, A. T., Wang, B., Rajaram, N., Wang, Q., Ramanujam, N., Palmer, G. M., & Dewhirst, M. W. (2012) · Journal of Biophotonics · doi:10.1002/jbio.201200187 · Cited by 20
Self-citationA fast numerical method for oxygen supply in tissue with complex blood vessel network
Lu, Y., Hu, D., & Ying, W. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247641 · Cited by 17
“For example, poor microcirculation structure results in local tissue hypoxia (low concentration of oxygen), which leads to the production of growth factors for angiogenesis, such as vascular endothelial growth factor (VEGF) [4, 5].”
BackgroundGertsenshteyn, I., Epel, B., Ahluwalia, A. S., Kim, H., Fan, X., Barth, E. D., Zamora, M. A., Markiewicz, E. J., Tsai, H., Sundramoorthy, S. V., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05889-4 · Cited by 16
Sánchez‐Castillo, A., & Kampen, K. R. (2024) · Discover Oncology · doi:10.1007/s12672-024-01544-6 · Cited by 19
“Additionally, the tumor-associated altered vasculature induces dynamic fluctuations in blood flow, and consequently, oxygen availability in distinctive diffuse patterns, a phenomenon known as cycling hypoxia [57, 58].”
Kimura, M., Rabbani, Z. N., MOURAVIEV, V. B., Tsivian, M., Vujašković, Ž., Satoh, T., Baba, S., Baust, J. M., Baust, J. G., & Polascik, T. J. (2010) · Cryobiology · doi:10.1016/j.cryobiol.2010.06.010 · Cited by 17
Positron emission tomography to assess hypoxia and perfusion in lung cancer
Verwer, E. E., Boellaard, R., & van der Veldt, A. A. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i5.824 · Cited by 21
Multimodal optical imaging of microvessel network convective oxygen transport dynamics
deDeugd, C. M., Wankhede, M., & Sorg, B. S. (2009) · Applied Optics · doi:10.1364/ao.48.00d187 · Cited by 18
Huang, M., Wu, C.-H., Huang, C., Chung, F., Huang, C., Tsai, H., Chen, C., Lin, S., & Wang, J. (2013) · BioMed Research International · doi:10.1155/2013/931028 · Cited by 17
Strategies for Pancreatic Cancer-Responsive Nanodrug Platforms Targeting Tumor Hypoxic Environments
Joo, K. S., Sym, S. J., Kim, K., & Khang, D. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s548825 · Cited by 22
Predictive markers of radiotherapy-induced rectal cancer regression
Shin, J.-S., Tut, T.-G., Ho, V., & Lee, C. S. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202494 · Cited by 19
Identification and validation of ferroptosis-related hub genes in obstructive sleep apnea syndrome
Liu, P., Zhao, D. H., Pan, Z., Tang, W., Chen, H., & Hu, K. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1130378 · Cited by 20
Rasouli, M., Fattahi, R., Nuoroozi, G., Zarei‐Behjani, Z., Yaghoobi, M., Hajmohammadi, Z., & Hosseinzadeh, S. (2023) · Cell and Tissue Banking · doi:10.1007/s10561-023-10099-9 · Cited by 18
“…the activation of the antioxidant defense system and promoting the expression of cell survival proteins and the genes involved in inflammation, cell transformation, tumor cell death or survival, proliferation, invasion, angiogenesis, and tumor migration (Dewhirst et al. 2008; Gupta et al. 2012).”
Spectral imaging reveals microvessel physiology and function from anastomoses to thromboses
Wankhede, M., Agarwal, N., Fraga-Silva, R. A., deDeugd, C. M., Raizada, M. K., Oh, S. P., & Sorg, B. S. (2010) · Journal of Biomedical Optics · doi:10.1117/1.3316299 · Cited by 16
“Acute episodes of hypoxia activate numerous tumor cell pathways, in particular those controlled by the hypoxiainducible factor 1 HIF-1 promoter, and these pathways enhance tumor cell survivability and treatment resistance.(81)”
BackgroundKarihtala, P., Maenpaa, J. U., Turpeenniemi-Hujanen, T. M., & Puistola, U. (2010) · PubMed · Cited by 16
Sleep apnoea and cancer: the new challenge
Levy, P. A., Godin‐Ribuot, D., & Pépin, J. (2014) · European Respiratory Journal · doi:10.1183/09031936.00065714 · Cited by 20
Johnston, H., Dickinson, P., Ivens, A. C., Buck, A. H., Levine, R. D., Remacle, F., & Campbell, C. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909455116 · Cited by 16
Knittelfelder, O., Delago, D., Jakse, G., Łukasiak, K., Thurner, E.-M., Thurnher, D., Pichler, M., Renner, W., Stranzl-Lawatsch, H., & Langsenlehner, T. (2020) · Cancers · doi:10.3390/cancers12030626 · Cited by 17
Drzyzga, A., Cichoń, T., Czapla, J., Jarosz–Biej, M., Pilny, E., Matuszczak, S., Wojcieszek, P., Urbaś, Z., & Smolarczyk, R. (2021) · Cancers · doi:10.3390/cancers13163924 · Cited by 15
New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer
Chiaradonna, F., Cirulli, C., Palorini, R., Votta, G., & Alberghina, L. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5854 · Cited by 19
Fu, J., Shao, Y., Shi, C. Y., Bu, W., & Zhu, Y. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01288g · Cited by 16
Cai, X., Freedman, B., & Witting, P. K. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12148 · Cited by 17
Barajas, R., Krohn, K., Link, J., Hawkins, R. A., Clarke, J. L., Pampaloni, M. H., & Cha, S. (2016) · Biomedicines · doi:10.3390/biomedicines4040024 · Cited by 17
Yoshida, K., Suzuki, S., Sakata, J., Utsumi, F., Niimi, K., Yoshikawa, N., Nishino, K., Shibata, K., Kikkawa, F., & Kajiyama, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8610 · Cited by 19
Li, J., Meng, X., Hu, J. R., Zhang, Y., Dang, Y., Wei, L., & Shi, M. (2017) · Europe PMC (PubMed Central) · Cited by 17
Murray, T. G., Houston, S. K. S., Piña, Y., Murray, T. G., Boutrid, H., Cebulla, C. M., Schefler, A. C., Shi, W., Celdran, M., Feuer, W. J., et al. (2011) · Clinical ophthalmology · doi:10.2147/opth.s15179 · Cited by 16
Jiang, M., Yin, X., Qin, B., Xuan, S., Yuan, X., Yin, H., Zhu, C., Li, X., Yang, J., Du, Y., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00663 · Cited by 19
Nasry, W. H. S., & Martin, C. K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.539361 · Cited by 17
Qiu, Y., Liu, Y.-F., Shu, X., Qiao, X., Ai, G., & He, X.-J. (2023) · Academic Radiology · doi:10.1016/j.acra.2023.06.011 · Cited by 18
Regional and Temporal Differences in Gene Expression of LH BETA T AG Retinoblastoma Tumors
Houston, S. K. S., Piña, Y., Clarke, J., Koru‐Sengul, T., Scott, W. K., Nathanson, L., Schefler, A. C., & Murray, T. G. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6321 · Cited by 16
Population dynamics inside cancer biomass driven by repeated hypoxia‐reoxygenation cycles
Zhang, C., Cao, S., & Xu, Y. (2015) · Quantitative Biology · doi:10.1007/s40484-014-0032-8 · Cited by 16
Significance of p27kip1as potential biomarker for intracellular oxidative status
Quintos, L., Lee, I. A., Kim, H. J., Lim, J.-S., Park, J., Sung, M., Seo, Y. R., & Kim, J. (2010) · Nutrition Research and Practice · doi:10.4162/nrp.2010.4.5.351 · Cited by 16
Redalen, K. R., Bratland, Å., Vlatkovic, L., Ragnum, H. B., Sælen, M. G., Olsen, D. R., Marignol, L. H., & Ree, A. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063723 · Cited by 16
Verma, A., Rich, L. J., Vincent–Chong, V. K., & Seshadri, M. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12705 · Cited by 15
Störz, P. (2013) · Springer eBooks · doi:10.1007/978-94-007-5787-5_15 · Cited by 21
Radiation Therapy for Glioma Stem Cells
Rizzo, A. E., & Yu, J. S. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16537-0_6 · Cited by 16
Nguyen, A., Moussallieh, F., Mackay, A. G., Çiçek, A. E., Coca, A. H., Chenard, M. P., Weingertner, N., Lhermitte, B., Letouzé, É., Guérin, É., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16500 · Cited by 18
Xue, Q., Zeng, S., Ren, Y., Pan, Y., Chen, J., Chen, N., Wong, K. K. Y., Song, L., Fang, C., Guo, J., et al. (2023) · Biomedical Optics Express · doi:10.1364/boe.499286 · Cited by 15
Imperative connotation of SODs in cancer: Emerging targets and multifactorial role of action
Panda, B., Tripathy, A., Patra, S., Kullu, B., Tabrez, S. S. M., & Jena, M. (2024) · IUBMB Life · doi:10.1002/iub.2821 · Cited by 15
“51,52 The ROS-mediated signaling facilitates VEGF secretion, and subsequent activation of the PI3K/Akt/mTOR pathway promotes tumorigenesis in a hypoxia-dependent/ independent manner.”
Wang, M., Chen, G., Hu, B., Zhang, F., Xu, Q., Li, L., Xi, Q., Liu, J., Yu, Z., Cao, P., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.017 · Cited by 15
Response of antioxidant defense system to chromium (VI)-induced cytotoxicity in human diploid cells
Asatiani, N. V., Abuladze, M. K., Kartvelishvili, T., Kulikova, N., Asanishvili, L., Holman, H. N., & Sapojnikova, N. A. (2009) · BioMetals · doi:10.1007/s10534-009-9276-6 · Cited by 17
“ROS are capable of causing direct damage effect or acting as critical intermediate signaling molecules leading to diverse biological consequences (Costa and Klein 2006; Dewhirst et al. 2008; Leonard et al. 2004).”
BackgroundHo, C. K., Kornaga, E. N., Klimowicz, A. C., Enwere, E. K., Dean, M. L., Bebb, G. D., Phan, T., Ghatage, P., Magliocco, A. M., Lees‐Miller, S. P., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.12.025 · Cited by 14
Kim, H., Lin, Q., & Yun, Z. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.047 · Cited by 13
Radiobiological Modifiers in Clinical Radiation Oncology: Current Reality and Future Potential
Allison, R. R. (2014) · Future Oncology · doi:10.2217/fon.14.174 · Cited by 14
Yi, H., Ji, D., Zhan, T., Yao, Y., Li, M., Jia, J., Li, Z., & Gu, J. F. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3620 · Cited by 16
Subcellular Energetics and Metabolism: A Cross-Species Framework
Thiele, R. H. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001773 · Cited by 15
Koyasu, N., Hyodo, F., Iwasaki, R., Eto, H., Elhelaly, A. E., Tomita, H., Shoda, S., Takasu, M., Mori, T., Murata, M., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.12.311 · Cited by 13
Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer
Yuan, M., Zhai, Y., Men, Y., Zhao, M., Sun, X., Ma, Z., Yang, X., Sun, S., Bao, Y., Liu, Y., et al. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14689 · Cited by 12
Bergeron, T., Zhang, R., Elliot, K. M., Rapin, N., MacDonald, V., Linn, K. A., Simko, E., & Misra, V. (2012) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2011.00310.x · Cited by 14
Bin, T. A. N. G., XiuMei, Z. H. O. U., & QiJun, Q. I. A. N. (2009) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/972009-495 · Cited by 14
König, M., Holzhütter, H., & Berndt, N. (2013) · Biotechnology Journal · doi:10.1002/biot.201200393 · Cited by 14
O’Donoghue, J. A., Guillem, J. G., Schöder, H. M., Lee, N. Y., Divgi, C. R., Ruby, J. A., Humm, J. L., Lee-Kong, S. A., Burnazi, E. M., Cai, S., et al. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-42 · Cited by 15
Lee, H., Yoon, C., Park, D. J., Kim, Y., Schmidt, B. H., Lee, Y., Tap, W. D., Eisinger‐Mathason, T. S. K., Choy, E., Kirsch, D. G., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.10.047 · Cited by 14
RetractedJing, S. W., Wang, J., & Xu, Q. (2017) · Tumor Biology · doi:10.1177/1010428317717983 · Cited by 13
Elingaard-Larsen, L. O., Rolver, M. G., Sørensen, E. E., & Pedersen, S. F. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_23 · Cited by 16
Chemotherapy and Radiotherapy Resistance: Complexity, Reality, and Promise
Ajani, J. A., Izzo, J. G., & Lee, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.7566 · Cited by 13
Frontiñán-Rubio, J., Llanos-González, E., García‐Carpintero, S., Peinado, J. R., Ballesteros‐Yáñez, I., Villar, M., de la Fuente, J., Pérez‐García, V. M., Pérez-Romasanta, L. A., Malumbres, M., et al. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00734-0 · Cited by 13
He, Y., Li, Z., Shi, X., Ding, J., & Wang, X. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231175189 · Cited by 14
Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers
Liew, L. P., Shome, A., Wong, W., Hong, C. R., Hicks, K. O., Jamieson, S. M. F., & Hay, M. P. (2023) · Molecules · doi:10.3390/molecules28114457 · Cited by 13
Gardner, L. L., Thompson, S. J., O’Connor, J. D., & McMahon, S. J. (2024) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ad70f0 · Cited by 19
Miao, X., Chen, T., Lang, Z., Wu, Y., Wu, X., Zhu, Z., & Xu, R. X. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02047b · Cited by 13
Kushal, S., Wang, H., László, C., Szabó, L., & Olenyuk, B. Z. (2010) · Biopolymers · doi:10.1002/bip.21550 · Cited by 12
Havelund, B. M., Sørensen, F. B., Pløen, J., Lindebjerg, J., Spindler, K. G., & Jakobsen, A. K. M. (2012) · Apmis · doi:10.1111/j.1600-0463.2012.02949.x · Cited by 12
Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis
Zhang, K., Wang, C., Wang, R., Chen, S., & Li, Z. (2019) · Journal of Visualized Experiments · doi:10.3791/59763 · Cited by 12
Kingsley, J., Costello, J. R., Raghunand, N., & Rejniak, K. A. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009206 · Cited by 11
Kimura, K., Iguchi, N., Nakano, H., Yasui, H., Matsumoto, S., Inanami, O., & Hirata, H. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0003 · Cited by 14
“Thus, nitroxyl radicals with a short lifetime in a living organism, such as 4-oxo-2,2,6,6-tetramethylpiperidine-N -oxyl (4-oxo-TEMPO, also called Tempone) radical, have not been used in EPR-based redox-sensitive mapping to date.”
Kotoku, N., Nakata, C., Kawachi, T., Sato, T., Guo, X., Ito, A., Sumii, Y., Arai, M., & Kobayashi, M. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.02.026 · Cited by 12
Kao, S., Tsai, M., Wu, C., Chen, J., Tseng, S.-H., Lin, S., & Chang, K. (2014) · Head & Neck · doi:10.1002/hed.23912 · Cited by 12
The impact of hypoxia on oncolytic virotherapy
Guo, Z. S. (2011) · Virus Adaptation and Treatment · doi:10.2147/vaat.s17832 · Cited by 20
Liang, X.-X., Li, Q., Su, Z. Z., Lan, X., OuYang, P., Mao, Y., Shi, D.-B., Deng, W., Cheng, Z.-B., Wang, S.-Y., et al. (2015) · Journal of Cancer · doi:10.7150/jca.11403 · Cited by 13
Gertsenshteyn, I., Epel, B., Barth, E. D., Leoni, L., Markiewicz, E. J., Tsai, H., Fan, X., Giurcanu, M. C., Bodero, D., Zamora, M. A., et al. (2021) · Radiology Imaging Cancer · doi:10.1148/rycan.2021200104 · Cited by 12
Carbogen gas and radiotherapy outcomes in prostate cancer
Yip, K., & Alonzi, R. (2012) · Therapeutic Advances in Urology · doi:10.1177/1756287212452195 · Cited by 11
Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era
Moding, E. J., Mowery, Y. M., & Kirsch, D. G. (2016) · The Cancer Journal · doi:10.1097/ppo.0000000000000203 · Cited by 16
Grandjean, M. M., Sermeus, A. B. L., Branders, S., Defresne, F., Dieu, M., Dupont, P., Raes, M. J., Ridder, M. D., & Féron, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076508 · Cited by 12
Yang, Q., Tang, P. C., He, G., Ge, S., Liu, L., & Zhou, X. (2017) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2017.03.013 · Cited by 11
Cancer Incidence in C3H Mice Protected from Lethal Total-Body Radiation after Amifostine
Cook, J. A., Naz, S., Anver, M. R., Sowers, A. L., Fabre, K. M., Krishna, M. C., & Mitchell, J. B. (2018) · Radiation Research · doi:10.1667/rr14987.1 · Cited by 11
Al-Mutawa, Y., Herrmann, A., Corbishley, C., Losty, P. D., Phelan, M. M., & Sée, V. (2018) · Bioscience Reports · doi:10.1042/bsr20180185 · Cited by 11
Nexrutine and exercise similarly prevent high grade prostate tumors in transgenic mouse model
Patel, D. I., Abuchowski, K., Bedolla, R. G., Rivas, P., Musi, N., Reddick, R. L., & Kumar, A. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226187 · Cited by 16
Omran, Z., Guise, C. P., Chen, L., Rauch, C., Abdalla, A. N., Abdullah, O., Sindi, I. A., Fischer, P. M., Smaill, J. B., Patterson, A. V., et al. (2021) · Molecules · doi:10.3390/molecules26113327 · Cited by 11
Yin, Z., Li, X., Zhang, Y., Tao, J., Yang, Y., Fang, S., Zhang, Z., Yuan, Y., Liu, Y., & Wang, S. (2022) · Magnetic Resonance in Medicine · doi:10.1002/mrm.29250 · Cited by 11
Isotopologous Organotellurium Probes Reveal Dynamic Hypoxia In Vivo with Cellular Resolution
Edgar, L. J., Vellanki, R. N., McKee, T. D., Hedley, D. W., Wouters, B. G., & Nitz, M. (2016) · Angewandte Chemie · doi:10.1002/ange.201607483 · Cited by 11
Fokas, E., Kamlah, F., Hänze, J., Engenhart‐Cabillic, R., Rose, F., & An, H. (2010) · Thoracic Cancer · doi:10.1111/j.1759-7714.2010.00029.x · Cited by 10
Metadata
- Authors
- Dewhirst, M. W., Cao, Y., & Moeller, B.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Dewhirst, Mark W.
- Venue
- Nature Reviews Cancer
- Published
- 2008-06
- Volume
- 8
- Issue
- 6
- Pages
- 425-437
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3943205
- OpenAlex
- W2016861891
- Cited by
- 1,022
- References
- 161
- Citations by year
- 2026: 27 · 2025: 29 · 2024: 30 · 2023: 52 · 2022: 60 · 2021: 70 · 2020: 76 · 2019: 44 · 2018: 64 · 2017: 53 · 2016: 73 · 2015: 65 · 2014: 63 · 2013: 63 · 2012: 62
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-07-03)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA40355, R01CA040355, P50CA068438)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- tumor hypoxia, free radicals, reactive oxygen species, reactive nitrogen species, HIF-1, tumor angiogenesis, radiotherapy response, tumor heterogeneity, immune cell infiltration, tumor cell survival, endothelial cells
- MeSH terms
- Animals, Free Radicals, Humans, Neoplasms, Neovascularization, Pathologic, Nitric Oxide, Oxygen, Cell Hypoxia, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.